{"retracted":false,"update":{"timestamp":1301443200000,"doi":"10.1007/s00280-011-1626-8","type":"correction"},"doi":"10.1007/s00280-011-1594-z","journal":"Cancer Chemotherapy and Pharmacology","publisher":"Springer Nature","title":"Erratum to: Phase II trial of cisplatin plus prednisone in docetaxel-refractory castration-resistant prostate cancer patients"}
